Objectives Swallowing impairment is a growing problem that affects 16% of the overall population and can significantly affect medicine-taking. However, little is known about the knowledge and practice of healthcare professionals (HCPs) relating to swallowing-impaired (SI) patients. The aim of this scoping review was to investigate the knowledge and practice of HCPs in supporting SI patients with their medicine-taking, to identify their reference sources, and to describe their training and information needs. Method Databases searched included Scopus, Web of Science, Medline and Google Scholar from inception to August 2017. Qualitative and quantitative studies describing knowledge and practice of HCPs relating to medicine use in SI patients were included. Key findings The nine included studies, from an initial 142, involved nurses (nine studies), pharmacists (one study) and doctors (two studies) in hospitals or aged-care facilities. A knowledge deficit linked to lack of training was revealed, particularly with identification of modified-release dosage forms, medication that can/cannot be crushed, vehicle for safe dispersion, consequences of inappropriate modification, drug stability and legal aspects. Written information sources were named, but not used in practice. Pharmacists were the primary experts for consultation, and were involved in nurse education, and were members of multidisciplinary teams. Conclusions Knowledge in nurses was inadequate, with practice indicating potentially serious medication-related errors. Additional training, either undergraduate or as continuing professional development, is recommended. Information to guide safe medicine modification practice should be accessible to all practitioners. Pharmacists could take the lead role in offering training to nurses.
Background
Dysphagia, or swallowing impairment, is a growing problem that affects 16% of the general population. [1] Those most affected are adults aged 65 and older (13%), patients with stroke (40-70%) or neurodegenerative diseases (60-80%), and patients who have received radiotherapy and/or surgical treatment for head and neck cancer (60-75%). [2] Dysphagic or swallowing-impaired (SI) patients experience over three times the frequency of medicine administration errors compared to patients with no swallowing difficulties. [3] Up to 69% of community pharmacy customers whom pharmacists suspected may have some degree of swallowing impairment admit to not taking a tablet or capsule due to difficulty with swallowing [4] which results in poor adherence to prescribed treatment. [5, 6] The oral route is the most widely used route of administration, with tablets and capsules being the solid oral dosage forms (SODFs) of choice for their convenience, accuracy of dosing, ease of handling, consistent quality and relatively low price. [7] Many patients who are unable to swallow their SODFs modify them by breaking/crushing tablets or opening capsules. [4] This is frequently done without the knowledge and advice of their healthcare professionals (HCPs). [4, 8, 9] Previous studies have found patient-reported or carer-reported prevalence of medication modification in the general community to be between 43% [10] and 68% [4] with almost half of the patients seemingly unaware of the dangers associated with modifying SODFs. [11, 12] A systematic review of older adults in long-term care facilities who had difficulty swallowing medicines found that SODF modification by nurses occurred in up to onethird of all occasions of medicine administration. [13] Disconcertingly, Paradiso et al. [14] reported that 18% of all medicines administered to the residents of 10 aged-care facilities were medicines for which there are concerns about modification. The incidence of institutional SODF modification has been found to vary from 26% in a UK hospital [15] to 34% in 10 South Australian aged-care facilities. In the latter case, 17% of the modifications were of medications that should not be altered, with 18% of all medicines administered to the residents being medicines for which there are concerns about modification. [14] Another Australian study in local public hospitals found that 79% of the nurses reported crushed tablets. [16] In a study set in community pharmacy, Lau et al. [12] found that 17.5% of 369 pharmacy customers reported swallowing difficulties, 11% reported modifying medication dosage forms, and, disconcertingly, almost half (44%) of those surveyed did not think there would be problems with modifying medicines.
Altering the SODF before administration can potentially lead to numerous problems: decreased accuracy of the dose, decreased efficacy, increased toxicity, reduced stability, alterations in pharmacokinetics, unpalatability and potential harm to the user. [8, 15, 17] SODFs should only be modified when either no suitable alternative exists or the alternate medicine poses a greater risk to the patient. [18] This includes suggesting an alternate route of administration, switching the drug to one in the same therapeutic class and ensuring that the same active pharmaceutical ingredient is compounded into a suitable dosage form. [19] Any change to the original dosage form registered by the manufacturer has related legal implications, [20] as crushing, breaking and opening of tablets/ capsules before administration will result in the product becoming unlicensed. [15, 21] This results in the prescriber, dispenser and administrator becoming liable for any adverse outcomes that occur as a result of taking the altered medicine. [22] Despite the many potential problems associated with SODF modification, little is known about HCP knowledge of this area, and the general level of competence in correctly advising and counselling SI patients about medicine-taking. McGillicuddy et al. [23] in their systematic review of the qualitative literature on SODF modification found that the key factors influencing the knowledge and attitudes of HCPs about the practice of modifying SODFs included inter-and intrapatient individuality and variability, and the complexity inherent in every aspect of the decision-making process of modifying SODFs. They also noted the lack of a formal, systematic communication process between HCPs and strongly advised that the decision-making process should be a multidisciplinary one based on evidence-based recommendations.
Despite pharmacists often being the first point of contact for patients, Nguyen et al. [8] noted that there is limited research focusing solely on pharmacist perspectives, experiences and knowledge of dosage form modification. The current involvement of different HCPs and their respective roles and practice of supporting SI patients with their medicine-taking practice appear to be unclear. Additionally, little is known about their level of knowledge, the adequacy of their training and the availability of information sources or guidelines to support them in their practice of advising SI patients with the modification and use of medicines. [9] The primary aim of this scoping review was to investigate the knowledge (evaluated or self-perceived) and practice of HCPs relating to supporting and advising SI patients with their medicine-taking practice in either hospital or community/ambulatory care settings. Secondary aims were to describe the roles of the various HCPs in either individual or collaborative practice, to identify their reference sources (written and/or interaction with fellow HCPs) and to describe their training and information needs.
Methods
The framework proposed by Arksey and O'Malley [24] and modified by Levac et al. [25] was used for this scoping review. Scoping reviews aim to map the literature on a particular topic or research area and provide an opportunity to identify key concepts; gaps in the research; and types and sources of evidence to inform practice, policymaking and research. [26] They also allow for a range of study designs and accommodate diverse outcomes. This is relevant to the current topic, where we anticipated only limited literature, and for which we aimed to gain a better understanding of HCP involvement, their knowledge and their opinions on training and of information resource usage.
Search strategy
Electronic databases including Scopus, Web of Science, Medline and Google Scholar were independently searched by both authors from inception of the database to November 2016. A repeat search was conducted in July 2017 using the same search strategy. Keywords and terms were identified and were incorporated into a search strategy suitable for individual databases. An example of the search strategy used for Medline, Scopus and Web of Science was as follows: (pharmacist OR nurse OR doctor OR physician OR healthcare professional OR speech language therapist OR physiotherapist OR swallowing therapist) AND (dysphagia OR swallowing disorder OR swallowing impairment) AND (medication OR tablet OR capsule OR solid oral dosage form OR dosage form modification) AND (knowledge OR practice). The reference lists of included papers were hand-searched, and citation searching was undertaken to identify any further potentially relevant articles. Prominent authors in the field were identified and author searches performed to identify additional articles.
Study selection
Following removal of duplicates, both reviewers screened titles to remove those irrelevant to the review. Abstracts of the remaining articles were assessed independently by both reviewers to remove studies that did not meet the stipulated inclusion and exclusion criteria. Finally, the full text of studies identified from the abstract screen was obtained and independently assessed by both reviewers. Any disagreement pertaining to inclusion of studies was discussed until resolution.
Eligibility
Inclusion criteria for studies were as follows: (1) written and available in English; (2) full paper describing a primary research study; (3) included either qualitative or quantitative study methodology, or a combination of methods; and (4) described knowledge and/or practice of HCPs when dealing with SI patients and their medicinetaking. Studies that included medicine administration via the enteral route, and secondary research resources such as reviews, opinion pieces, commentaries, editorials and conference abstracts were excluded.
Data extraction
Both reviewers contributed to all phases of the data extraction process. An extraction form specific to this study was developed. Apart from factual information such as author names, year of publication and country in which research was conducted, data extracted included aim and/or objectives, profession of participants, study design, study setting, method of data collection, knowledge, practice, information needs, availability of information/current resources, prior training and training needs. Both reviewers then independently assessed each study and extracted the relevant data. Any disagreements were discussed until consensus was reached. For this review, severity of the dysphagia was not considered, and the term 'swallowing impairment' relates to any difficulty experienced when swallowing SODFs. The general term 'modified-release' (MR) is used to describe all extendedrelease products (controlled-release, sustained-release) as well as delayed-release products (e.g. enteric-coated).
Data analysis
As a scoping review aims to provide an overview of evidence and explore evidence gaps, rather than answer a narrow question, statistical pooling of data was not the intention. For our scoping review, results from included studies are summarised descriptively.
Results

Study selection
Initially, 142 articles were identified, with 110 remaining after excluding duplicates. These 110 were then screened by title, which excluded 74, leaving a total of 36 articles for abstract review. The abstract screening process eliminated a further 21 articles, resulting in 15 full-text articles that were assessed for eligibility. Seven of these articles met the stipulated criteria for inclusion. A search of reference lists yielded two additional eligible articles, resulting in a total of nine articles being included. A repeat search was conducted in July 2017 but did not yield any additional articles. Figure 1 outlines the article selection process.
Characteristics of included studies are summarised in Table 1 . Study designs of included studies were crosssectional, [8, [27] [28] [29] intervention-based with no control group, [18, 30] qualitative, [31] mixed-methods [27, 32] or observational. [18, 27, 33] The size of the HCP study samples in these studies ranged from six to 448, and publication dates ranged from 2006 to 2015. Four of the studies were undertaken in Australia, [8, 18, 31, 33] two in the UK [27, 32] and one each from Qatar, [30] Oman [29] and Germany. [28] All studies were conducted in institutions, including hospitals and aged-care settings. Knowledge and/or practice of HCPs was addressed in all nine studies: seven included nurses only, [18, 27, [29] [30] [31] [32] [33] one included doctors and nurses, [28] and the remaining one included pharmacists, doctors and nurses. [8] Availability/lack of current information sources (written and/or HCP) was reported in six studies. [8, 27, 28, [31] [32] [33] The need for adequate information and training was stressed in all nine papers.
Knowledge and practice of HCPs
Data on knowledge and practice were collected from selfcompleted questionnaires, [8, [27] [28] [29] [30] 32] self-reported verbal opinions of knowledge [27, [31] [32] [33] and observer-rated compliance with guidelines. [18, 33] Topics included compliance with guidelines for modifying SODFs, [18] the identification of SODFs that should not be modified, [8, 28, 30] the purpose, different types, suffixes and modification of MR dosage forms, [8, [28] [29] [30] crushing and administering multiple medications [27] and drug stability issues. [8] Consideration was given to the choice of a suitable vehicle for dispersion and viscosity issues, [27, [31] [32] [33] and alternative formulations that could be offered. [27] Other topics relating to knowledge and practice addressed potential harm to the administrator when modifying SODFs, [8] the use of protective gloves when crushing SODFs [29] and legal considerations in modifying SODFs. [32] The prevalence of dysphagia, [8] problems caused by conditions associated with dysphagia [27] and assessment of patients to establish the need to modify SODFs due to swallowing difficulties [31] were also noted as topics. Knowledge was reported as inadequate in all three of the health professions studied.
Two intervention studies assessed nurse knowledge both before and after an education and training intervention. [18, 30] One of these studies that aimed to improve knowledge and drug administration in SI patients [30] reported an overall increase in knowledge scores, including identification of MR codes (0-40%), and an increase from 51% to almost 90% for knowledge relating to the purpose and consequences of crushing MR preparations. In the other study aimed at assessing compliance with guidelines for the preparation of medication for SI patients, [18] knowledge improvement was evident from an increased proportion of medication safely prepared (45-91%) and in medication prepared optimally (33-60%).
Based on the results of a self-completed knowledge questionnaire, three articles reported a knowledge deficit [8, 28, 29] and four described self-reported nurse concern regarding their lack of knowledge in this area. [27, [31] [32] [33] Knowledge of nurses was found to be inadequate in the following areas: identification of MR suffixes, [8, 29, 30] safety risks associated with destroying the tablet coating, [8, 28] knowledge of the legal and professional issues associated with medicine modification [32] and potential safety risks for the person manipulating the SODF. [8] Knowledge questionnaires identified poor knowledge in both GPs [8, 28] and pharmacists. [8] Doctors also had inadequate knowledge of MR suffixes and of the safety risks for the person modifying the SODF [28] with the results similar to those found in nurses. In the only study that included all three classes of HCPs, [8] 40% of nurses, 62% of doctors and 73% of pharmacists identified stomach irritation as a potential problem when MR tablets were modified in all patients regardless of the condition being treated. Half of the participants expressed concern with modifying drugs that have a narrow therapeutic index. Pharmacists (75%), nurses (37%) and GPs (34%) correctly identified that certain drugs (in this case azathioprine) can cause harm to the administrator, but few participants identified that modifying antibiotics can also constitute a risk to the administrator. Overall, knowledge levels were found to vary greatly within the nursing profession, as well as between nurses, pharmacists and doctors. [18, 31] Data on practice extracted from included studies related largely to the modification of SODFs and their administration to SI patients by nurses. Additional practice areas included systematic patient assessment to identify swallowing problems and multidisciplinary practice. Nurse-reported difficulties associated with the practice of administering medicines to SI patients included problems preparing the medicine, the time-consuming nature of modifying and then administering medicines to older patients, particularly those with swallowing difficulties, and a lack of both knowledge and advice. [17, 27, 28] One paper described the practice environment of nurses as a complex and 'messy' one, with multiple demands on nurses that often then affords inadequate time for a systematic, orderly approach to medicine modification. [31] Nurses indicated having significant concerns regarding administering medicines to patients with dysphagia. [27] A study from Oman found that 77% of nurses regularly crush oral solids for SI patients, but only half check the pharmaceutical characteristics of oral solids before crushing. Although a high 87% reported being aware of certain SODFs that should not be crushed, only 38% correctly stated how these could be identified. [29] Of 160 observations during medication rounds at aged-care facilities, 32% of instances of SODF modification by nursing staff were identified as inappropriate. [33] A UK study reported that, of 24 SODFs that were crushed, in seven of the cases, a liquid formulation was available and could have been substituted. [27] Other reported problems included crushing multiple medications prescribed for SI patients in the same vessel and mixing with a vehicle, [29, 33] not cleaning the equipment between patients, [33] medication spillage [33] and medication loss due to incomplete administration of the vehicle containing the medicine. [33] More than half of nurses (~52%) rarely/never use gloves during crushing. [29] When asked to identify any knowledge gaps, nurses acknowledged their lack of knowledge pertaining to medicines in general and particularly medicine modification and use in SI patients. [18, [27] [28] [29] [30] 32, 33] This included identifying medicines that were safe to crush, [27] [28] [29] appropriate vehicles for dispersion of crushed tablet, [27, 29, 32] and dosage variation due to altered bioavailability when changing from a solid to a liquid formulation. [27] Nurses were found to be more likely to ask patients about their ability to swallow medications, as compared to GPs and pharmacists, [8] whereas GPs were most likely to only target patients who were predisposed, or who had pre-existing conditions that would precipitate swallowing problems. [8] Collaborative practice was identified as key to improving practice, and its current absence is evidenced in the finding that 16% of nurses assume the prescriber has considered the characteristics of the SODF before prescribing it. [29] In addition, nurses noted receiving conflicting advice from the different health professions when approaching them for guidance. [31] Collaboration among nurses and pharmacists, with pharmacists providing more pharmaceutically based information for nurses, was seen as a desirable practice in improving medicine modification. [31] This has been implemented in some facilities where all medication issues are discussed with a multidisciplinary team (including a pharmacist) at the weekly team meeting, with team decisions then being communicated to nurses on the ward. [32] Others have reported that although there did not appear to be a formal multidisciplinary collaboration process to assist in making decisions, the nurses discussed individual medication needs with pharmacists and doctor. [31] Information sources consulted for guidance All studies included the information sources that were consulted. A major concern reported in a few papers was the lack of information available, notably pharmaceutical information on safe medication modification to support nurses, and guidance on how to access and use available resources. [31] [32] [33] Different professional disciplines (nursing, medicine and pharmacy) involved in residential care had conflicting opinions as there was no formal guide to best practice. [31] Where adequate resources were available, it was noted that none of them were used in practice during observed medication rounds, and a lack of knowledge on how to locate and use these resources was evident. [33] Written reference sources that were consulted included hospital electronic drug information systems, facility-produced guidelines, information produced by Trusts (in the case of nurses practising in the UK) or national formularies. [18, 28, 31, 33] Nurses in one study commented that, despite written sources usually being available, they were more comfortable seeking advice from another HCP. [18] Doctors and pharmacists reportedly consulted either reference texts or asked advice from each other.
The pharmacist was cited as a reference source in all nine studies. Most nurses chose to consult a pharmacist first when requiring information about crushing MR and coated tablets. [8, 29, 33] After a training intervention, all nurses cited the pharmacist as first choice for a consult. [18] One study found that a speech and language therapist was preferred for advice over a pharmacist. [27] Information needs identified
The findings from our review indicate that nurses need practical information to support their medicine modification practice. This includes specific pharmaceutical information, guidelines regarding optimal preparation, for example the maximum exposure time for drug mixtures, tablets/capsules that can/cannot be modified, safety aspects for the preparing person and a protocol to help standardise the mixing process. [28, 31, 32] In addition, these need to be easily accessible and well-structured resources (such as freely accessible databases) that offer detailed information. [28] Annotated advice on the medicine chart was seen as helpful, but not all charts had space for pharmacist notes. [27] Education and training Only two of the included studies mentioned training (of nurses) prior to the study. Almost a third of nurse participants reported that their preregistration training had not provided adequate preparation for administering medicines to SI patients. The remainder commented that the training that they received had occurred at the bedside and that no formal theory was presented in lectures. [27] This was supported by findings from the second study that describes exposure to the practice of co-mixing during undergraduate placements. However, this information was usually anecdotal rather than evidence based and depended primarily on the experience of the placement tutor.
The need for education and training was emphasised in all included studies. In one intervention study, [30] feedback from nursing staff was extremely positive as they appreciated the practical solutions provided which aided better compliance with guidelines and overall improved patient care. Ongoing continuing professional development and education for nurses was the most frequently reported need, [8, 31, 32] along with appropriate undergraduate and postgraduate training to assist nurses in their medication administration role. [27, 31, 32] Nurses felt that they would benefit from basic education and training in drug stability issues, [32] updates on dysphagia and its management from speech and language therapists, updates on medicines management, medication modification and aspects of medicine safety. [27] Improved staff training on how to locate and use available resources is needed to reduce the observed high incidence of inappropriate medication crushing. [33] Practice can be improved if training is targeted, practical and meaningful. [18] Discussion This scoping review is the first to interrogate the knowledge and practice of nurses, pharmacists and doctors involved in supporting SI patients in medicines use. Both measured and self-reported nurse knowledge were poor, and the limited research involving pharmacist and doctors also suggested inadequate knowledge. Despite major knowledge gaps, nurses emerged as the health professionals most actively involved in the hands-on practice of medicine modification and administration to SI patients. The small number of studies meeting the inclusion criteria for the review highlights the lack of systematic, evidence-based research in this area.
Limitations associated with this review included the small number of studies included, and the variable study methods and diversity of evidence which precluded the extraction of consistent, quality data relating to knowledge and practice. The dominance of the nursing profession limits generalisability of the review findings. A further limitation is associated with the search strategy; only the word 'modification' of dosage forms was used, whereas other descriptors such as crushing, dispersion and tampering were not included.
Previous research reports inadequate nurse knowledge of pharmacology, solid dosage form characteristics, drug management (regulation, storage, dispensing) and drug dose calculation. [34] [35] [36] Our review findings show that nurses lacked knowledge on drug stability, degradation and bioavailability issues, formulations that should not be crushed and the consequences of crushing these preparations, and codes used by pharmaceutical manufacturers indicating MR dosage forms. [8, [28] [29] [30] 32] In practice, this knowledge inadequacy implies that almost two of three SI patients would be exposed to risks associated with inappropriate tablet crushing [29] and is also reflected in an Australian audit of oral medicine modification by nurses for SI patients which found that 55% of the medications were not prepared in compliance with national guidelines. [17] The limited data suggesting inadequate knowledge in doctors could have a knock-on effect as nurses tend to adopt a 'doctor knows best' strategy, relying on doctors to prescribe appropriately for SI patients. [32] Improved prescriber awareness of the size and availability of different formulations, as well as the difficulties associated with their administration would positively inform appropriate prescribing. [32] Based on their comprehensive training, pharmacists are theoretically well positioned to support SI patients with their medicine-related needs. This review found that pharmacists were not directly involved in the practice of modifying and administering medicines, or in counselling SI patients. Pharmacists were the main reference source consulted for information on this topic despite one study suggesting that pharmacists had inadequate knowledge. [8] Although guidelines, charts informing practice and lists of specially formulated SODFs that should not be modified are available online, [19, 30, 37, 38] this information may not be easily and rapidly accessible, and nurses may not be adequately trained in its use. [30] An educational role for pharmacists was identified involving the training of fellow health professionals [18] and pharmacists were also included in a multidisciplinary team ensuring optimal management of SI patients. [32] The prevalence of direct pharmacist involvement (individually or as part of a team) in medicines management of SI patients, and their confidence and knowledge to adopt such a role, is unknown.
Review findings highlight the need for education and training, as formal training in caring for SI patients and their medicine-taking needs does not appear to be included in medical, nursing or pharmacy undergraduate curricula. [27] Nurses reported that their knowledge of dysphagia and medicines management was not formally included in their lectures, but rather learnt anecdotally through their experiences at the bedside. [27] The prediction that people aged 65 and over will account for about 25% of the total population of developed countries by 2050 [17] emphasises the importance of the knowledge and skills required to support medicine use in these patients being included either at the undergraduate level or in continued professional development programmes.
Suggestions for further research include a quantitative investigation of knowledge, attitude and practice of different HCPs pertaining to medicines management of SI patients in hospitals, nursing or aged-care homes, and in community pharmacy. As the advice-seeking behaviour of nurses and doctors for medicines modification information is unknown, a project focusing on this issue in hospitals and in ambulatory care would be useful. Research could also assess the impact of a pharmacistled, in-house, continuing educational intervention for nurses focusing on safe medicine modification practices. Particularly valuable would be research investigating a collaborative practice model intervention, longitudinally tracking its impact on medicine administration errors and the opinions of team members on multidisciplinary practice.
Implications for pharmacy practice
Pharmacists should routinely screen for swallowing problems, particularly in elderly patients, and should ensure they are equipped to manage and advise on medicine use in SI patients. As nurses play a major role in medicine administration, despite a reported lack of knowledge and easy access to information, pharmacists should ensure the availability of relevant information and guidelines and promote safe practice by presenting training courses to nurses on medicine modification. Pharmacists could initiate the establishment of a multidisciplinary team to support safe medicine use in SI patients.
Conclusion
A knowledge deficit in medicines management of SI patients was identified in nurses, which has serious implications for potential medication-related errors. Insufficient evidence exists to comment conclusively on knowledge of pharmacists and doctors. Pharmacists are the preferred source for information and advice despite one study suggesting they may be inadequately equipped to do so. They also adopted an educational role in delivering in-house training to nurses. A multidisciplinary practice model should be explored to deliver optimal care to this patient group.
